2013 Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Trends, Metrics and Financials

  2013 Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Trends,
                            Metrics and Financials

  PR Newswire

  MUMBAI, India, February 21, 2013

MUMBAI, India, February 21, 2013 /PRNewswire/ --

Bharat Book Bureau (
http://www.bharatbook.com/healthcare-market-research-reports/complete-2012-13-induced-pluripotent-stem-cell-industry-report.html
) has recently added the market intelligence report titled " The Complete
2012-13 Induced Pluripotent Stem Cell Industry Report - Market Metrics,
Dynamics, and Trends ."

It provides strategic insights that guide the decision-making of companies
that develop and manufacture induced pluripotent stem cell (iPSC) research
products.

 (Logo: http://photos.prnewswire.com/prnh/20130128/590935 )

The market intelligence report presents financial metrics for the Induced
Pluripotent Stem Cell Industry, as well as key findings discovered from
surveying a global audience of iPSC researchers (293 respondents). It reveals
iPSC product and industry trends with five-year projections; informs about
iPSC grants, patents and publications; identifies profitable opportunities for
producers of iPSC products, and presents critical insights into future tools
that iPSC scientists will require. In addition, it clearly denotes preferred
species for iPSC research, analyzes the competitive environment for iPSC
research products, and breaks down market share by competitor - providing an
overall view of the iPSC product landscape.

iPSCs are adult stem cells that have been transformed into embryotic-like stem
cells through the manipulation of gene expression and similar methods. Despite
some initial concerns, induced pluripotent stem cells (iPSC) are now sold by
more than half (53.4%) of U.S. research product companies and 38.7% of
research product companies worldwide.

"It is clear that iPSC products are in high demand within the scientific
community. Currently, it is difficult for stem cell research product
suppliers, like BD BioSciences, Life Technologies, and others, to know what
products iPSC scientists will demand in 2013 and beyond. The needs of
scientists are constantly changing, so this market intelligence report reveals
profitable opportunities for providers of iPSC research products to pursue,"
says BioInformant.

For the past five decades, stem cell research has provided insights to the
inner workings of the body and cell regeneration. "Therapeutic applications of
iPSCs represent the future of medicine," says BioInformant. The scientific
community believes that one day stem cell research will assist in finding
viable treatments for crippling diseases such as Parkinson's, Alzheimer's,
spinal cord injuries and more.

"This is a must-read industry report for research supply companies to
optimally position themselves to sell iPSC research products. This is a
lucrative and rapidly expanding market," explains BioInformant. "The study
will help you understand your key strengths relative to the competition."

The study is backed by a 100% money back guarantee, to ensure that the
strategies, findings and tools are found helpful.

To learn more about "The Complete 2012-13 Induced Pluripotent Stem Cell
Industry Report - Market Metrics, Dynamics, and Trends," please visit
http://www.bharatbook.com/healthcare-market-research-reports/complete-2012-13-induced-pluripotent-stem-cell-industry-report.html
for details.

Request for Sample pages -
http://www.bharatbook.com/RequestSample.asp?pid=331461

Table ofContents

I. Abstract

II. Background

III. Timeline

IV. Research Applications

V. Characterization Of iPSC Research Advances

VI. Companies Selling iPSC Research Products

VII. Types Of iPSC Research Products

VIII. Companies Developing iPSC Therapies

A. Commerical Entities

1. ViaCyte

2. Fate Therapeutic

3. iPerian

4. Cellular Dynamics

5. Mesoblast

B. Non-Commercial Organizations Developing iPSC Therapies

IX. Strategic Collaborations For Development OF iPSC Products

A. Life Technologies

B. Lonza Group AG

C. EMD Millipore

D. Sigma Aldrich

E. Roslin Cells, Ltd.

F. ArunA Biomedical

G . CeeTox and Cellular Dynamics

X. Market Trend Analysis

X. Market Size

XII. Scientist Panel: Detailed End-User Survey

XIII. Strategies For Accessing The Marketplace

XIV. Conclusions

Get an overview of the report at or request for sample pages at -

http://www.bharatbook.com/healthcare-market-research-reports/complete-2012-13-induced-pluripotent-stem-cell-industry-report.html

For Complete range of Related Reports:

Stem Cells - http://www.bharatbook.com/StemCells.html

Clinical Trial   -  http://www.bharatbook.com/ClinicalTrial

Pharmaceutical & Healthcare -
http://www.bharatbook.comPharmaceuticals-and-Healthcare.html

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that
provides market research reports, industry analysis, company profiles,
business reports, country reports, newsletters and online databases. Our
clients include Corporate, Consulting firms, and Academic Institutions and
Government departments across the globe. Bharat Book Bureau provides over a
million reports from more than 400 publishers around the globe. The market
research reports we provide, help global companies examine the different
markets before setting up a business or expanding into different countries
across the world. They give a complete perspective on the current market
scenario, trends, segments and future outlook.

Contact us: Poonam Bharat Book BureauIndia : +91-22-27810772,
27810773USA/Canada - 1-866-279-8368 (Toll free) Skype - bharatbook E-mail :
poonam@bharatbook.com Website : http://www.bharatbook.com
 
Press spacebar to pause and continue. Press esc to stop.